L’USAGE DE DROGUES EN FÉDÉRATION WALLONIE-BRUXELLES

136
l’usage de drogues en Fédération Wallonie-bruxelles || rapport 2011-2012
Sasse, A., Verbrugge, R. & Van Beckhoven, D. Épidémiologie du SIDA et de l’infection au VIH en Belgique.
Situation au 31 décembre 2011 ; Institut Scientifique de Santé Publique : Bruxelles.
Simon, O. (2003). Le double diagnostic manqué et ses conséquences thérapeutiques. Primary Care, 3, 60-
61.
Small, W., Rhodes, T., Wood, E., & Kerr, T. (2007). Public injection settings in Vancouver : physical
environment, social context and risk. International Journal on Drug Policy, 18, 27-36.
The Gallup Organisation (2011). Youth attitudes on drugs. Analytical Report. European Commission :
Luxembourg.
Thomas, D. L., Vlahov, D., Solomon, L., Cohn S., Taylor, et al. (1995). Correlates of hepatitis C virus
infections among injection drug users. Medicine, 74, 212-220.
Thorpe, L. E., Ouellet, L. J., Hershow, R., Bailey, S. L., Williams, I.T ., et al. (2002). Risk of hepatitis C virus
infection among young adult injection drug users who share injection equipment. American Journal of
Epidemiology, 155, 645-653.
Todts, S., Glibert, P., Van Malderen, S., Saliez, V., Hogge, M. & Van Huyck, C. (2009). Usage de drogues dans
les prisons belges : Monitoring des risques sanitaires. Service Public Fédéral Justice : Bruxelles.
Tortu, S., McMahon, J. M., Pouget, E. R., & Hamid, R. (2004). Sharing of noninjection drug-use implements
as a risk factor for Hepatitis C. Substance Use and Misuse, 39, 211-224.
UNODC (2009). Rapport Mondial sur les Drogues. Office des Nations Unies contre la Drogue et le Crime :
Vienne.
Van der Laenen, F., De Ruyver, B., Christiaens, J., & Lievens, D. (2011). Drugs in cijfers III : Onderzoek naar de
overheidsuitgaven voor het drugsbeleid in België : eindrapport. Academia Press : Gent.
Värnik, A., Kõlves, K., van der Feltz-Cornelis, C. M., Marusic, A., Oskarsson, H. et al. (2008). Suicide
methods in Europe : a gender-specific analysis of countries participating in the «European Alliance
Against Depression”. Journal of Epidemiology and Community Health, 62, 545-551.
Westermeyer J. (2006). Comorbid schizophrenia and substance abuse : a review of epidemiology and
course. American Journal on Addictions, 15, 345-355.
Wood, E., Kerr T, Spittal, P. M., Li, K., Small, W., et al. (2003). The potential public health and community
impacts of safer injecting facilities : evidence from a cohort of injection drug users. Journal of Acquired
Immune Deficiency Syndromes, 32, 2-8.
Wood, E., Kerr, T., Montaner, J. S., Strathdee, S. A., Wodak, A., et al. (2004). Rationale for evaluating North
America’s first medically supervised safer injecting facility. The Lancet Infectious Diseases, 4, 301-306.
Wood, E., Tyndall, M., zhang, R., Stoltz, J.A., Lai, C., et al. (2006). Attendance at supervised injecting
facilities and use of detoxification services. New England Journal of Medicine, 354, 2512-2513.